General Article | Veterinary Clinical Medicine

Cost-Benefit Analysis of Vaccination Against Haemorrhagic Septicaemia in Bovines

D. Bardhan, G. Ananda Sekaran, M. Chilambarasan, G. Singh, R. Pal and Sanjay Kumar

ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly (U.P.) - 243 122

Published in the Indian Veterinary Journal October 2021 : 98 (10) - pages 23 to 27
(Received: , Accepted: )


The study attempted to assess the benefitcost ratio (BCR) of the vaccination against Haemorrhagic Septicaemia (HS) to control HS. A farm-level sample survey was carried out in 2017, using a stratified multistage sampling technique, covering the major agro-climatic regions of the country to estimate the economic loss due to HS. The benefit of vaccination against HS was avoidance of the HS induced economic losses, while the costs of vaccination included both the costs of vaccine and vaccination. Per animal loss, if left, vaccinated was the highest in buffalo (INR 20,296), followed by crossbred cow (INR 13,044) and indigenous cow (INR 11,904). The BCR calculated ranged from 12 to 24 in all the breeds/species of bovines, indicating that controlling HS through vaccination is economically viable.

Key Words: Haemorrhagic Septicaemia, vaccination, Benefit-Cost Ratio

Main Article

Access to the IVJ Digital Archives is restricted to our paid subscribers. Please consider becoming a subscriber to continue reading this article.